Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5510)
Rapport Therapeutics, Inc. (RAPP)
Bredt David — Chief Scientific Officer
Shares
8,300
Price
$26.83
Total Value
$222.65K
Shares Held After
395,775
% of Holdings
2.1%
InspireMD, Inc. (NSPR)
Gleason Shane Thomas — Chief Commercial Officer
Shares
2,909
Price
$1.58
Total Value
$4.59K
Shares Held After
1,197,462
% of Holdings
0.2%
Amylyx Pharmaceuticals, Inc. (AMLX)
Cohen Joshua B — Director
Shares
136,193
Price
$13.59
Total Value
$1.85M
Shares Held After
3,378,621
% of Holdings
3.9%
Amylyx Pharmaceuticals, Inc. (AMLX)
Klee Justin B. — Director
Shares
136,193
Price
$13.58
Total Value
$1.85M
Shares Held After
3,378,546
% of Holdings
3.9%
Harmony Biosciences Holdings, Inc. (HRMY)
Kapadia Sandip — CHIEF FINANCIAL OFFICER
Shares
20,961
Price
$35.92
Total Value
$752.83K
Shares Held After
0
% of Holdings
100.0%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
6,303
Price
$19.89
Total Value
$125.36K
Shares Held After
1,005,732
% of Holdings
0.6%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
5,590
Price
$19.89
Total Value
$111.18K
Shares Held After
890,604
% of Holdings
0.6%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
6,303
Price
$19.89
Total Value
$125.36K
Shares Held After
1,005,732
% of Holdings
0.6%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
5,590
Price
$19.89
Total Value
$111.18K
Shares Held After
890,604
% of Holdings
0.6%
Sharps Technology, Inc. (STSS)
Saba Capital Management, L.P. — 10% Owner
Shares
25,000
Price
$2.30
Total Value
$57.50K
Shares Held After
1,524,170
% of Holdings
1.6%
Nkarta, Inc. (NKTX)
HASTINGS PAUL J — Director
Shares
26,046
Price
$2.07
Total Value
$53.92K
Shares Held After
390,023
% of Holdings
6.3%
Nkarta, Inc. (NKTX)
Mahmood Nadir — President
Shares
5,649
Price
$2.07
Total Value
$11.69K
Shares Held After
167,727
% of Holdings
3.3%
CareDx, Inc. (CDNA)
Hanna John Walter JR — Director
Shares
10,156
Price
$21.05
Total Value
$213.80K
Shares Held After
616,885
% of Holdings
1.6%
Phreesia, Inc. (PHR)
VanDuyn Amy Beth — SVP, Human Resources
Shares
687
Price
$16.38
Total Value
$11.25K
Shares Held After
159,551
% of Holdings
0.4%
Phreesia, Inc. (PHR)
Roberts Evan — President, Provider Solutions
Shares
1,810
Price
$16.38
Total Value
$29.65K
Shares Held After
832,822
% of Holdings
0.2%
Phreesia, Inc. (PHR)
Linetsky David — President, Network Solutions
Shares
1,743
Price
$16.38
Total Value
$28.55K
Shares Held After
229,980
% of Holdings
0.8%
Phreesia, Inc. (PHR)
Indig Chaim — Director
Shares
3,038
Price
$16.38
Total Value
$49.76K
Shares Held After
1,371,130
% of Holdings
0.2%
Phreesia, Inc. (PHR)
Hoffman Allison C — General Counsel & Secretary
Shares
1,106
Price
$16.38
Total Value
$18.12K
Shares Held After
173,656
% of Holdings
0.6%
Phreesia, Inc. (PHR)
Gandhi Balaji — Chief Financial Officer
Shares
975
Price
$16.38
Total Value
$15.97K
Shares Held After
155,256
% of Holdings
0.6%
Ceribell, Inc. (CBLL)
Parvizi Josef — Director
Shares
25,000
Price
$22.94
Total Value
$573.50K
Shares Held After
747,652
% of Holdings
3.2%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
149
Price
$18.02
Total Value
$2.68K
Shares Held After
213,992
% of Holdings
0.1%
Dynavax Technologies Corporation (DVAX)
Novack David F — President & COO
Shares
114,000
Price
$15.64
Total Value
$1.78M
Shares Held After
63,344
% of Holdings
64.3%
Beam Therapeutics Inc. (BEAM)
Bellon Christine — Chief Legal Officer
Shares
559
Price
$35.40
Total Value
$19.79K
Shares Held After
97,038
% of Holdings
0.6%
Beam Therapeutics Inc. (BEAM)
Bellon Christine — Chief Legal Officer
Shares
15,959
Price
$34.72
Total Value
$554.07K
Shares Held After
97,597
% of Holdings
14.1%
Beam Therapeutics Inc. (BEAM)
Bellon Christine — Chief Legal Officer
Shares
2,111
Price
$33.62
Total Value
$70.98K
Shares Held After
113,556
% of Holdings
1.8%
Akanda Corp. (AKAN)
HRT FINANCIAL LP — 10% Owner
Shares
29,036
Price
$1.40
Total Value
$40.65K
Shares Held After
15,684
% of Holdings
185.1%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Webster Brian Daniel — Director
Shares
15,000
Price
$22.80
Total Value
$342.02K
Shares Held After
394,786
% of Holdings
3.7%
Vivani Medical, Inc. (VANI)
Williams Gregg — Director
Shares
264,551
Price
$1.26
Total Value
$333.33K
Shares Held After
26,564,109
% of Holdings
1.0%
Vivani Medical, Inc. (VANI)
Williams Gregg — Director
Shares
1,473,214
Price
$1.12
Total Value
$1.65M
Shares Held After
26,299,558
% of Holdings
5.6%
Immuneering Corp (IMRX)
Schall Thomas J. — Director
Shares
21,645
Price
$4.67
Total Value
$101.04K
Shares Held After
74,530
% of Holdings
29.0%
ANAPTYSBIO, INC (ANAB)
Marquet Magda — Director
Shares
1,710
Price
$48.85
Total Value
$83.53K
Shares Held After
9,930
% of Holdings
14.7%
ANAPTYSBIO, INC (ANAB)
Marquet Magda — Director
Shares
9,290
Price
$48.12
Total Value
$447.00K
Shares Held After
11,640
% of Holdings
44.4%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
12,563
Price
$5.10
Total Value
$64.07K
Shares Held After
650,298
% of Holdings
1.9%
Olema Pharmaceuticals, Inc. (OLMA)
Kovacs Shane William Charles — CH. OPERATING & FINANCIAL OFF.
Shares
100,000
Price
$28.73
Total Value
$2.87M
Shares Held After
139,727
% of Holdings
41.7%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
2,932
Price
$40.02
Total Value
$117.35K
Shares Held After
44,525
% of Holdings
6.2%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
37,413
Price
$0.55
Total Value
$20.58K
Shares Held After
2,198,642
% of Holdings
1.7%
Cannabis Sativa, Inc. (CBDS)
TOBIAS DAVID — Director
Shares
91,000
Price
$0.02
Total Value
$1.77K
Shares Held After
26,258,951
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
40
Price
$474.74
Total Value
$18.99K
Shares Held After
36,781
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,576
Price
$471.44
Total Value
$742.99K
Shares Held After
36,821
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
3,531
Price
$469.34
Total Value
$1.66M
Shares Held After
38,397
% of Holdings
8.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
407
Price
$472.28
Total Value
$192.22K
Shares Held After
41,928
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,307
Price
$470.37
Total Value
$614.77K
Shares Held After
42,335
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,439
Price
$468.32
Total Value
$673.92K
Shares Held After
43,642
% of Holdings
3.2%
Olema Pharmaceuticals, Inc. (OLMA)
Harmon Cyrus — Director
Shares
3,489
Price
$29.12
Total Value
$101.60K
Shares Held After
737,770
% of Holdings
0.5%
Phreesia, Inc. (PHR)
Hui Yvonne — Principal Accounting Officer
Shares
365
Price
$16.36
Total Value
$5.97K
Shares Held After
29,545
% of Holdings
1.2%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
13,112
Price
$45.20
Total Value
$592.61K
Shares Held After
108,964
% of Holdings
10.7%
Acrivon Therapeutics, Inc. (ACRV)
Blume-Jensen Peter — Director
Shares
49,000
Price
$1.68
Total Value
$82.12K
Shares Held After
2,095,771
% of Holdings
2.3%
Acrivon Therapeutics, Inc. (ACRV)
Levy Adam D. — Chief Financial Officer
Shares
8,832
Price
$1.70
Total Value
$15.00K
Shares Held After
20,983
% of Holdings
42.1%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
470
Price
$83.79
Total Value
$39.38K
Shares Held After
1,192,987
% of Holdings
0.0%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
5,386
Price
$83.16
Total Value
$447.90K
Shares Held After
1,193,457
% of Holdings
0.4%
Showing 3951–4000 of 5510 transactions (page 80 of 111)